MDedge Psychcast

Caroline Bonham, MD, and Avi Kriechman, MD, join Psychcast host Lorenzo Norris, MD, via phone to discuss enhancing resilience in rural communities. Overall U.S. life expectancy decreased from 78.7 years to 78.6 years from 2016 to 2017. Researchers from the Centers for Disease Control and Prevention noted that, along with drug overdose deaths, suicide also drove the decrease in average lifespan over that time period. Addressing suicide in rural communities presents unique challenges.

Dr. Bonham is vice chair of community behavioral health in the department of psychiatry and behavioral sciences at the University of New Mexico, Albuquerque. Dr. Kriechman is a child, adolescent and family psychiatrist at the university, where he serves as principal investigator on ASPYR – Alliance-building for Suicide Prevention & Youth Resilience.

You can hear more on resilience and suicide from the MDedge Psychcast in these past episodes:

•  
•  
•  
• Find the MDedge Psychcast where ever you listen:

Amazon

Apple Podcasts

Google Podcasts

Spotify


 

Caroline Bonham, MD, and Avi Kriechman, MD, join Psychcast host Lorenzo Norris, MD, via phone to discuss enhancing resilience in rural communities. Overall U.S. life expectancy decreased from 78.7 years to 78.6 years from 2016 to 2017. Researchers from the Centers for Disease Control and Prevention noted that, along with drug overdose deaths, suicide also drove the decrease in average lifespan over that time period. Addressing suicide in rural communities presents unique challenges.

Dr. Bonham is vice chair of community behavioral health in the department of psychiatry and behavioral sciences at the University of New Mexico, Albuquerque. Dr. Kriechman is a child, adolescent and family psychiatrist at the university, where he serves as principal investigator on ASPYR – Alliance-building for Suicide Prevention & Youth Resilience.

You can hear more on resilience and suicide from the MDedge Psychcast in these past episodes:

•  
•  
•  
• Find the MDedge Psychcast where ever you listen:

Amazon

Apple Podcasts

Google Podcasts

Spotify


 

Caroline Bonham, MD, and Avi Kriechman, MD, join Psychcast host Lorenzo Norris, MD, via phone to discuss enhancing resilience in rural communities. Overall U.S. life expectancy decreased from 78.7 years to 78.6 years from 2016 to 2017. Researchers from the Centers for Disease Control and Prevention noted that, along with drug overdose deaths, suicide also drove the decrease in average lifespan over that time period. Addressing suicide in rural communities presents unique challenges.

Dr. Bonham is vice chair of community behavioral health in the department of psychiatry and behavioral sciences at the University of New Mexico, Albuquerque. Dr. Kriechman is a child, adolescent and family psychiatrist at the university, where he serves as principal investigator on ASPYR – Alliance-building for Suicide Prevention & Youth Resilience.

You can hear more on resilience and suicide from the MDedge Psychcast in these past episodes:

•  
•  
•  
• Find the MDedge Psychcast where ever you listen:

Amazon

Apple Podcasts

Google Podcasts

Spotify


 

In this episode, the inaugural guest on the MDedge Psychcast, Henry A. Nasrallah, MD, returns to lecture on first-episode psychosis from the Psychopharmacology Update meeting in Cincinnati. Dr. Nasrallah is editor in chief of Current Psychiatry and is the Sydney W. Souers Endowed Chair and professor and chairman of the department of neurology and psychiatry and behavioral neuroscience at Saint Louis University.

If you would like to respond to any of Dr. Nasrallah’s comments in this Masterclass, email us at podcasts@mdedge.com.

Amazon
Apple Podcasts
Google Podcasts
Spotify






 

In this episode, the inaugural guest on the MDedge Psychcast, Henry A. Nasrallah, MD, returns to lecture on first-episode psychosis from the Psychopharmacology Update meeting in Cincinnati. Dr. Nasrallah is editor in chief of Current Psychiatry and is the Sydney W. Souers Endowed Chair and professor and chairman of the department of neurology and psychiatry and behavioral neuroscience at Saint Louis University.

If you would like to respond to any of Dr. Nasrallah’s comments in this Masterclass, email us at podcasts@mdedge.com.

Amazon
Apple Podcasts
Google Podcasts
Spotify






 

In this episode, the inaugural guest on the MDedge Psychcast, Henry A. Nasrallah, MD, returns to lecture on first-episode psychosis from the Psychopharmacology Update meeting in Cincinnati. Dr. Nasrallah is editor in chief of Current Psychiatry and is the Sydney W. Souers Endowed Chair and professor and chairman of the department of neurology and psychiatry and behavioral neuroscience at Saint Louis University.

If you would like to respond to any of Dr. Nasrallah’s comments in this Masterclass, email us at podcasts@mdedge.com.

Amazon
Apple Podcasts
Google Podcasts
Spotify






 

In this masterclass edition, Joseph Goldberg, MD, gives a talk on the first episode of major depression. Dr. Goldberg is a clinical professor of psychiatry at the Ichan school of medicine at Mount Sinai in New York City.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 

In this masterclass edition, Joseph Goldberg, MD, gives a talk on the first episode of major depression. Dr. Goldberg is a clinical professor of psychiatry at the Ichan school of medicine at Mount Sinai in New York City.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 

In this masterclass edition, Joseph Goldberg, MD, gives a talk on the first episode of major depression. Dr. Goldberg is a clinical professor of psychiatry at the Ichan school of medicine at Mount Sinai in New York City.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 

The 38th episode of the Psychcast includes the best of from this year in psychopharmacology. In this episode we go back to the summer for two master classes on ketamine and stimulants, respectively and we drop in on two conversations between Lorenzo Norris, MD on anxiety and comorbid ADHD as well as a conversation on benzodiazapines. The Psychcast will be back with new content in 2019.

Amazon
Apple
Google
Spotify

The 38th episode of the Psychcast includes the best of from this year in psychopharmacology. In this episode we go back to the summer for two master classes on ketamine and stimulants, respectively and we drop in on two conversations between Lorenzo Norris, MD on anxiety and comorbid ADHD as well as a conversation on benzodiazapines. The Psychcast will be back with new content in 2019.

Amazon
Apple
Google
Spotify

The 38th episode of the Psychcast includes the best of from this year in psychopharmacology. In this episode we go back to the summer for two master classes on ketamine and stimulants, respectively and we drop in on two conversations between Lorenzo Norris, MD on anxiety and comorbid ADHD as well as a conversation on benzodiazapines. The Psychcast will be back with new content in 2019.

Amazon
Apple
Google
Spotify

In this episode, Roberto Lewis-Fernandez, MD, joins MDedge Psychiatry Editor-in-Chief, Lorenzo Norris, MD, to talk about how cultural assessments work and why they’re imperative to person-centered care. More from Dr. Lewis-Fernandez, Curbside Consult: Chinese American man with high risk of psychosis.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 

In this episode, Roberto Lewis-Fernandez, MD, joins MDedge Psychiatry Editor-in-Chief, Lorenzo Norris, MD, to talk about how cultural assessments work and why they’re imperative to person-centered care. More from Dr. Lewis-Fernandez, Curbside Consult: Chinese American man with high risk of psychosis.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 

In this episode, Roberto Lewis-Fernandez, MD, joins MDedge Psychiatry Editor-in-Chief, Lorenzo Norris, MD, to talk about how cultural assessments work and why they’re imperative to person-centered care. More from Dr. Lewis-Fernandez, Curbside Consult: Chinese American man with high risk of psychosis.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify
 

Jack Drescher, MD, joins Lorenzo Norris, MD, to talk about issues surrounding conversion therapy. Dr. Drescher is a psychiatrist and psychoanalyst in private practice in New York City. In this episode he explains issues with the therapy as well as how to treat patients who have undergone this “therapy.”

In 2016, Dr. Drescher and his colleagues authored a report that reviews the history of conversion therapy and offers guidelines for government regulations as well as for other regulatory bodies.

He and his colleagues wrote that “peer-reviewed literature from multiple professional organizations, including the American Psychiatric Association and the American Psychological Association, have found no evidence that conversion therapy treatments result in changes in sexual orientation.” They also noted that there is evidence suggesting that these treatments are harmful.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify
 

Jack Drescher, MD, joins Lorenzo Norris, MD, to talk about issues surrounding conversion therapy. Dr. Drescher is a psychiatrist and psychoanalyst in private practice in New York City. In this episode he explains issues with the therapy as well as how to treat patients who have undergone this “therapy.”

In 2016, Dr. Drescher and his colleagues authored a report that reviews the history of conversion therapy and offers guidelines for government regulations as well as for other regulatory bodies.

He and his colleagues wrote that “peer-reviewed literature from multiple professional organizations, including the American Psychiatric Association and the American Psychological Association, have found no evidence that conversion therapy treatments result in changes in sexual orientation.” They also noted that there is evidence suggesting that these treatments are harmful.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify
 

Jack Drescher, MD, joins Lorenzo Norris, MD, to talk about issues surrounding conversion therapy. Dr. Drescher is a psychiatrist and psychoanalyst in private practice in New York City. In this episode he explains issues with the therapy as well as how to treat patients who have undergone this “therapy.”

In 2016, Dr. Drescher and his colleagues authored a report that reviews the history of conversion therapy and offers guidelines for government regulations as well as for other regulatory bodies.

He and his colleagues wrote that “peer-reviewed literature from multiple professional organizations, including the American Psychiatric Association and the American Psychological Association, have found no evidence that conversion therapy treatments result in changes in sexual orientation.” They also noted that there is evidence suggesting that these treatments are harmful.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify
 

From GAP 2018, Lorenzo Norris, MD, welcome Ashwin Patkar, MD, to discuss the opioid epidemic and how North Carolina is approaching it systemically. And later, Dr. RK knows that some of your patients are blue this time of year, she joins us to talk about what that is and what you can do about it.

In an evidence-based review, Dr. Patkar overviews the issue and includes dosages and references for FDA-approved buprenophine and burprenorphine/naloxone formulation. Click here to read that review.
Amazon Alexa
Apple Podcasts
Google Podcasts  ​​​​​
Spotify

From GAP 2018, Lorenzo Norris, MD, welcome Ashwin Patkar, MD, to discuss the opioid epidemic and how North Carolina is approaching it systemically. And later, Dr. RK knows that some of your patients are blue this time of year, she joins us to talk about what that is and what you can do about it.

In an evidence-based review, Dr. Patkar overviews the issue and includes dosages and references for FDA-approved buprenophine and burprenorphine/naloxone formulation. Click here to read that review.
Amazon Alexa
Apple Podcasts
Google Podcasts  ​​​​​
Spotify

From GAP 2018, Lorenzo Norris, MD, welcome Ashwin Patkar, MD, to discuss the opioid epidemic and how North Carolina is approaching it systemically. And later, Dr. RK knows that some of your patients are blue this time of year, she joins us to talk about what that is and what you can do about it.

In an evidence-based review, Dr. Patkar overviews the issue and includes dosages and references for FDA-approved buprenophine and burprenorphine/naloxone formulation. Click here to read that review.
Amazon Alexa
Apple Podcasts
Google Podcasts  ​​​​​
Spotify

In this edition, the Psychcast welcomes back Dr. Jack Rozel for an update on Pittsburgh in the wake of the Tree of Life shooting.

In this edition, the Psychcast welcomes back Dr. Jack Rozel for an update on Pittsburgh in the wake of the Tree of Life shooting.

In this edition, the Psychcast welcomes back Dr. Jack Rozel for an update on Pittsburgh in the wake of the Tree of Life shooting.

Scientists have been warning about climate change for years, but psychiatrists may soon need to follow suit. In this edition of the Psychcast, Lorenzo Norris, MD, welcomes Robin Cooper, MD, to discuss the impacts of global climate change on both patients and communities.

Dr. Cooper “has been in private practice with a focus on both psychotherapy and medical management throughout her 35 years of practice.”

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify


 

Scientists have been warning about climate change for years, but psychiatrists may soon need to follow suit. In this edition of the Psychcast, Lorenzo Norris, MD, welcomes Robin Cooper, MD, to discuss the impacts of global climate change on both patients and communities.

Dr. Cooper “has been in private practice with a focus on both psychotherapy and medical management throughout her 35 years of practice.”

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify


 

Scientists have been warning about climate change for years, but psychiatrists may soon need to follow suit. In this edition of the Psychcast, Lorenzo Norris, MD, welcomes Robin Cooper, MD, to discuss the impacts of global climate change on both patients and communities.

Dr. Cooper “has been in private practice with a focus on both psychotherapy and medical management throughout her 35 years of practice.”

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify


 

In this episode of the MDedge Psychcast, Lorenzo Norris, MD and Petros Levounis, MD, discuss pharmacological and psychosocial options for treating patients with substance abuse disorders including alcohol, opiates, and even the holy grail -- cocaine. And Dr. DK wants you to know that it’s time for sanity.

In this episode of the MDedge Psychcast, Lorenzo Norris, MD and Petros Levounis, MD, discuss pharmacological and psychosocial options for treating patients with substance abuse disorders including alcohol, opiates, and even the holy grail -- cocaine. And Dr. DK wants you to know that it’s time for sanity.

In this episode of the MDedge Psychcast, Lorenzo Norris, MD and Petros Levounis, MD, discuss pharmacological and psychosocial options for treating patients with substance abuse disorders including alcohol, opiates, and even the holy grail -- cocaine. And Dr. DK wants you to know that it’s time for sanity.